Balanced news tone
News Sentiment
OSL sentiment intelligence
OncoSil Medical Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
39 relevant articles
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
+40.7% over one week, +55.9% over four weeks, trend inactive, and below fair value.
OncoSil Medical: Is Medtech Comeback Finally Here?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
79/100 classification
One-week reaction
40.7%
Price confirming higher
Trend fit
Trend inactive
55.9% over four weeks
Fair value
-66.4%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
38
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Kalkine
Direct company coverage
OncoSil Medical: Is Medtech Comeback Finally Here?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:22
- Source
- Kalkine
Kalkine
Direct company coverage
OncoSil Medical (ASX:OSL): Cancer-Treatment Stock Jumps as Biotech Traders Return
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 13:02
- Source
- Kalkine
Barron's
Direct company coverage
This Undervalued Medical-Devices Stock Is Poised for a Rebound
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 11:01
- Source
- Barron's
Market source
Direct company coverage
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 14:49
- Source
- Market source
Stocks Down Under
Direct company coverage
OncoSil Medical (ASX:OSL) flags a catalyst-heavy back half of 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 00:53
- Source
- Stocks Down Under
The Globe and Mail
Direct company coverage
Medical Devices & Supplies - Specialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 Jun 2026 07:00
- Source
- The Globe and Mail
Kalkine
Direct company coverage
OncoSil Medical (ASX:OSL) Enters Final FDA HDE Review Stage: Market Impact Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Kalkine
grafa.com
Direct company coverage
OncoSil Medical enters final FDA review stage for HDE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 04:47
- Source
- grafa.com
Kalkine
Direct company coverage
OncoSil Medical (ASX:OSL) Slides as Investors Reassess Healthcare Micro-Cap
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:21
- Source
- Kalkine
Seeking Alpha
Direct company coverage
Medical device and healthcare services stocks lead sector's EPS revision rankings (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jun 2026 07:00
- Source
- Seeking Alpha
Kalkine
Direct company coverage
Is Growing Clinical Adoption Supporting Momentum for Oncosil Medical (ASX:OSL)?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Kalkine
Market source
Direct company coverage
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Finance News Network
Direct company coverage
Daily Special: EBR Systems, OncoSil Medical, xReality Group
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- Finance News Network
Kalkine Media
Direct company coverage
Could All Ordinaries TGA Approval Lift OncoSil Focus?
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 20 May 2026 07:00
- Source
- Kalkine Media
Kalkine
Direct company coverage
OncoSil Medical (ASX:OSL) Shares Skyrocket ~54% Today- Here's Why?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- Kalkine
smallcaps.com.au
Direct company coverage
OncoSil Medical Secures TGA Approval in Australia for Pancreatic Cancer Device
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 20 May 2026 02:47
- Source
- smallcaps.com.au
StockStory
Direct company coverage
Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- StockStory
Market source
Direct company coverage
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Favourable Signals For OncoSil Medical: Numerous Insiders Acquired Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Mar 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
intelligentinvestor.com.au
Direct company coverage
Oncosil Medical Limited (ASX: OSL) - Announcements
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Mar 2026 07:00
- Source
- intelligentinvestor.com.au
Market source
Direct company coverage
Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 Mar 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Winners And Losers Of Q4: Stryker (NYSE:SYK) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Mar 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source
Market source
Direct company coverage
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Mar 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Mar 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Market source